Takeaways from DSEI UK 2025

Scaling towards positive EBIT

Launches new product with Saab

Margin expansion and EBIT in sight

Planting more growth seeds

Higher growth, but also a bit higher cost

Clavister Holding AB: 1 director

A director at Clavister Holding AB bought 28,000 shares at 3.720SEK and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...

We raise estimates on good activity

A new breakthrough partnership

Outlook unchanged

New defence order, and more to come

Feedback from ABGSC's Investor Days

Better than expected, continues to execute

Solid Q3, on track for positive EBIT 2025e

Order bonanza

Growth acceleration on the cards for H2

New defence partnership with Thales

Strong business momentum continues

Q2e: sales +18% and EBITDA +38% y-o-y. We raise our EBITDA estimates by 10-6% on '24e-'26e. Positive EBIT now within reach; 17-7x EV/EBITDA '24e-'26e.

Swedish Armed Forces places new CV90 order

Better-than-expected growth acceleration

25% organic growth, 13% ARR growth y-o-y. Slightly higher opex offset by better gross margin. Trading at 12-5x EV/EBITDA '24e-'26e.